Concepedia
Publication | Open Access
Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas
100
Citations
27
References
2005
Year
Page 1